Stock Market & Financial Investment News

News Breaks February 1, 2013 08:48 EDT MRK Merck says decision to wait on odanacatib filing made internally Says decision made internally with consultation from experts, not based on consultation with FDA. News For MRK From The Last 14 Days Check below for free stories on MRK the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 23, 2013 17:04 EDT MRK Merck's preladenant gave no evidence of efficacy, ends regulatory filing pursuit Subscribe for More Information May 22, 2013 18:52 EDT MRK On The Fly: After Hours Movers UP AFTER EARNINGS: Hewlett-Packard (HPQ), up 13.4% after reporting second quarter earnings that beat expectations and guiding third quarter and full-year earnings above estimates... Pacific Sunwear (PSUN), up 14.3%. ALSO HIGHER: Merck (MRK), up 0.2% after an FDA advisory panel voted 13-3 in support of the safety of initial doses of its insomnia drug suvorexant. DOWN AFTER EARNINGS: DryShips (DRYS), down 4.7%. ALSO LOWER: Apricus Biosciences (APRI), down 11.5% after filing to sell an ungiven amount of stock... NCI Building Systems (NCS) after being replaced by Cynosure (CYNO) in the S&P 600 as of May 31. 18:32 EDT MRK Merck's suvorexant for insomnia reviewed by FDA advisory committee Subscribe for More Information 18:06 EDT MRK Merck insomnia drug gets FDA panel backing, WSJ reports Merck's insomnia drug suvorexant received a favorable 13-3 vote from an FDA panel on the drug's two proposed starting doses, with the panel splitting the vote on the safety of higher doses, reports the Wall Street Journal. Reference Link 16:16 EDT MRK FDA panel votes 13-3 that Merck insomnia drug safe in low doses, Bloomberg says Subscribe for More Information 16:00 EDT MRK Options Update; May 22, 2013 Subscribe for More Information 14:52 EDT MRK FDA panel says Merck insomnia drug effective as sleep aid, Bloomberg reports Subscribe for More Information 09:39 EDT MRK Active equity option families trading Subscribe for More Information 07:45 EDT MRK FDA Peripheral & Central Nervous System Drugs Advisory Committee holds a meeting Subscribe for More Information May 21, 2013 18:56 EDT MRK On The Fly: After Hours Movers Subscribe for More Information 17:03 EDT MRK Merck announces $5B share repurchase Subscribe for More Information 17:01 EDT MRK Merck announces $5B accelerated share repurchase Subscribe for More Information 07:44 EDT MRK Sachs Associates to host a forum Subscribe for More Information May 20, 2013 17:49 EDT MRK Merck sleep drug effective, dosages questioned, WSJ reports Subscribe for More Information 07:32 EDT MRK Society for Information Display / IHS to host a conference Display Week 2013 is being held in Vancouver, British Columbia on May 19-24. May 16, 2013 08:55 EDT MRK BofA/Merrill's pharmaceuticals analysts hold analyst/industry conference call Subscribe for More Information May 14, 2013 17:39 EDT MRK Moody's lowers Merck's guaranteed debt to A1 from Aa3; stable outlook Moody's Investors Service lowered the long-term ratings of Merck by one notch, including the guaranteed senior unsecured rating to A1 from Aa3 and the non-guaranteed senior unsecured rating to A2 from A1. This action concludes a review for downgrade initiated on May 1, 2013. At the same time, Moody's affirmed Merck's Prime-1 commercial paper rating. The rating outlook is stable. May 10, 2013 11:48 EDT MRK Drugmakers to face pressure on U.S. prices, Reuters says Subscribe for More Information 06:53 EDT MRK GlaxoSmithKline, Merck to discount cancer vaccine in poor nations, NY Times says Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.